AI In Osteoarthritis: Transforming Diagnosis, Treatment, And Patient Care
Published on: December 15, 2025
AI In Osteoarthritis: Transforming Diagnosis, Treatment, And Patient Care
  • Article author photo

    Fatemeh Hashemzadeh

    MRes in Tissue Engineering and Innovation Technology – King’s College London; MSc in Biophysics

  • Article reviewer photo

    Esra Belhimer

    BSc (Hons) Biotechnology, The University of Manchester

Introduction

Osteoarthritis (OA) is a chronic joint disease that causes cartilage breakdown in joints, leading to bone reshaping and tissue inflammation. OA results in joint pain, stiffness, and movement restriction. OA is a leading form of arthritis worldwide, affecting more than 600 million people. Its prevalence grows with age, obesity, and joint damage, leading to higher healthcare expenses and diminished quality. The diagnosis of OA remains difficult because no dependable molecular markers exist for this condition, so doctors instead rely on imaging tests and clinical signs, which appear after major joint damage has taken place. The medical field currently treats symptoms through pain relief drugs, lifestyle modifications, and joint replacement surgery for severe cases. However, there are currently no methods to alter or cure the disease state.1,3

The field of Artificial Intelligence (AI) focuses on creating computer systems that execute tasks which would otherwise require the use of human intelligence. Computer systems are able to learn, reason, and make decisions through their advanced features involving natural language processing, computer vision, and predictive analytics. AI technology has made fast progress and has become increasingly used in the healthcare industry. It serves multiple purposes in healthcare by enhancing diagnostic precision, creating personalised treatment plans, streamlining administrative work, and advancing medical research to achieve better data processing speed and disease detection at earlier stages.4,7

This article investigates the use of AI technology in diagnosing and treating OA and its resulting influence on medical treatment for patients. AI provides early disease detection through its advanced imaging analysis, machine learning, and predictive modelling capabilities, allowing clinicians to identify early joint changes and potential risks before severe damage occurs. AI also allows doctors to analyse patient data for personalised medical care, aiding in the development of individualised treatment plans,  treatment forecasts, and accelerating the creation of disease-changing medications. The application of AI enables remote patient monitoring and mobile health platforms that enhance patient involvement and clinical decisions, enhancing the quality of life and decreasing healthcare expenses for OA patients.3,8

AI in the diagnosis and treatment of OA

AI serves as a strong medical instrument that helps doctors identify and manage OA through improved patient treatment methods. The implementation of AI in diagnosis allows for early detection as machine learning algorithms review X-rays and MRIs to identify small structural changes that humans would otherwise miss. This leads to better detection of OA symptoms during its onset. AI imaging analysis tools do this by applying predictive models to individual disease risk assessments and personalised evaluations, which combine genetic profiles with personal characteristics and lifestyle data. The use of automated diagnostic systems enables clinicians to reduce human errors and establish standardised testing procedures, leading to accelerated clinical workflows. 

AI systems in treatment enable customised treatment planning using individual patient data analysis and adaptive algorithms that modify treatment approaches based on patient advancement. For example, AI platforms in rehabilitation and physical therapy generate customised exercise plans that virtual assistants help patients perform at home while tracking their progress to modify the programmes according to their recovery milestones. Additionally, the predictive modelling speeds up drug development and therapy optimisation through the discovery of fresh pharmacological candidates and enhanced current treatment methods.9,12

AI in patient care and management

AI enables real-time tracking of joint mobility, pain, and activity through wearable sensors to enhance patient care by improving monitoring, assistance, engagement, and outcome prediction in various domains. Self-powered knee torque sensors and related devices now enable ongoing data acquisition for OA and injury rehabilitation care outside medical facilities. AI-based remote health monitoring lets doctors track your vital signs and activities after appointments, which helps manage diseases and decreases hospital return rates through early detection alerts. AI algorithms detect small disease progression indicators, which enable doctors to modify treatment plans and enhance patient results for a multitude of diseases at the same time, including OA, Alzheimer's disease, cancer, and heart disease. 

The system additionally provides better patient involvement through AI-based educational content delivery, which matches individual reading abilities, cultural backgrounds, and medical situations for improved understanding and treatment adherence. Virtual health assistants powered by AI chatbots and apps deliver continuous support to answer medical enquiries, assess symptoms, and generate personalised health advice, which extends medical care to unsupported population groups. The combination of AI-powered monitoring systems and reminder technologies enhances patient therapy adherence. This is demonstrated by research showing that real-time pill tracking and feedback systems lead to better medication adherence rates. 

Furthermore, AI predictive analytics processes electronic health records and genetic data to create long-term risk predictions, which doctors then apply to create individualised treatment strategies for identifying patients who might develop complications. AI provides quantifiable advantages to patients and medical providers through better monitoring, patient engagement, treatment adherence, and improved outcomes by delivering personalised care and faster services across all healthcare sectors.13,17

Challenges and ethical considerations

When AI is utilised in healthcare, it raises a number of challenges and ethical concerns. The four main concerns in the use of AI in healthcare are data privacy and security, algorithmic bias, clinical integration, and patient trust. It is critical to protect patient data since healthcare AI requires sensitive information that must be secure at rest and in transit to prevent data breaches and misuse. However, the process of de-identification does not eliminate the risk of re-identification since anonymised data still contains information that can be used to identify patients, which violates their privacy. 

Additionally, AI algorithms pose a major issue because their training with unrepresentative or biased datasets leads to the reinforcement of existing gaps, which results in unfair outcomes and incorrect medical diagnoses for disadvantaged populations. AI requires training with various data sets while being monitored by humans and exact algorithm development to combat these biases. The implementation of AI tools in clinical settings faces three main challenges because they need to work with existing systems and require external validation of their models, so healthcare staff must receive proper training for effective use. The problem of uninterpretable models persists because doctors require AI recommendations they can understand to make decisions they can trust. Healthcare AI systems will achieve patient trust only through patient understanding of AI operational methods, data management practices, privacy risks, and discrimination potential. The process of building trust involves honest communication with others and proper data management. Therefore, AI development for healthcare requires developers to work with medical staff and patient users who will use these systems while upholding ethical standards.18,21

Future directions and potential of AI in OA

The development of AI technology for OA care shows great promise because of modern technological progress, which enables better diagnostic methods and individualised treatment approaches, and continuous patient health tracking. AI models using MRI, biochemical, and clinical data for OA progression prediction represent a major diagnostic breakthrough, enabling doctors to detect conditions earlier and with greater precision. 

The medical field will experience a total transformation because GPT-5 and other AI tools analyse complex information to generate individualised treatment strategies and monitor disease progression in real time, enabling doctors to provide customised care to their patients. AI systems will work together with healthcare providers through a clinical support system which uses large data sets to generate insights, while physicians maintain their decision-making power to create a collaborative system that produces better results for patients. 

AI technology now supports diagnostic and preoperative planning for hip and spine conditions in addition to knee OA through its advanced image recognition abilities and patient-specific treatment modelling. AI implementation in clinical operations and patient care management will create substantial improvements in musculoskeletal healthcare through precise, individualised care that anticipates patient needs in the upcoming years.22,26

Conclusion

Artificial Intelligence (AI) technology brings major improvements to osteoarthritis (OA) treatment through enhanced diagnostic techniques and customised patient care and treatment strategies. AI technologies use advanced imaging and biomarker evaluation to detect hidden joint changes that standard assessment methods cannot detect, which allows doctors to begin treatment before symptoms worsen. AI generates customised treatment strategies by continuously tracking a combination of genetic information, clinical data, and lifestyle information, which it uses to modify therapy.

The system allows clinicians to process multiple data sources, which results in improved decision quality and better medical coordination for enhanced patient care. The research needs to advance AI models for clinical deployment while developing their ability to treat different musculoskeletal health conditions that exceed OA treatment. The advancement of biomarkers will lead to better predictive models and customised treatment approaches, which will produce better patient outcomes and superior quality of life for OA patients. The implementation of AI technology in OA care creates a revolutionary healthcare advancement that delivers improved proactive patient-centred care for managing this common chronic condition more efficiently.

References

  1. Damiani G, Bragazzi NL, Karimkhani Aksut C, Wu D, Alicandro G, McGonagle D, et al. The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study. Front Med [Internet]. 2021 [cited 2025 Oct 3]; 8:743180. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2021.743180/full.
  2.  Quicke JG, Conaghan PG, Corp N, Peat G. Osteoarthritis year in review 2021: epidemiology & therapy. Osteoarthritis and Cartilage [Internet]. 2022 [cited 2025 Oct 3]; 30(2):196–206. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1063458421009341.
  3. Mohammadi S, Salehi MA, Jahanshahi A, Shahrabi Farahani M, Zakavi SS, Behrouzieh S, et al. Artificial intelligence in osteoarthritis detection: A systematic review and meta-analysis. Osteoarthritis and Cartilage [Internet]. 2024 [cited 2025 Oct 3]; 32(3):241–53. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1063458423009482.
  4. Gjødsbøl IM, Ringgaard AK, Holm PC, Brunak S, Bundgaard H. The robot butler: How and why should we study predictive algorithms and artificial intelligence (AI) in healthcare? DIGITAL HEALTH [Internet]. 2024 [cited 2025 Oct 3]; 10:20552076241241674. Available from: https://journals.sagepub.com/doi/10.1177/20552076241241674.
  5. Abu-Hanna A. Artificial Intelligence in Medicine: 12th Conference on Artificial Intelligence in Medicine in Europe, AIME 2009, Verona, Italy, July 18-22, 2009, Proceedings. Berlin, Heidelberg: Springer Berlin / Heidelberg; 2009.
  6. Itkan Health Consulting, Riyadh, Saudi Arabia, Dabdoub F, Colangelo M, CIO, Alliance for Artificial Intelligence in Healthcare, Saudi Arabia, Aljumah M, Ministry of Health, Saudi Arabia, et al. Artificial Intelligence in Healthcare and Biotechnology: A Review of the Saudi Experience. J Arti Inte & Cloud Comp [Internet]. 2022 [cited 2025 Oct 3]; 1–6. Available from: https://www.onlinescientificresearch.com/articles/artificial-intelligence-in-healthcare-and-biotechnology-a-review-of-the-saudi-experience.pdf.
  7. Department of Kinesitherapy, Faculty of Public Health, Healthcare and Sports, South-West University ", Neofit Rilski", Blagoevgrad, Bulgaria., Subeva P, Gramatikova M, Department of Kinesitherapy, Faculty of Public Health, Healthcare and Sports, South-West University “Neofit Rilski” Blagoevgrad, Bulgaria. THE ROLE POTENTIAL OF ARTIFICIAL INTELLIGENCE IN KNEE OSTEOARTHRITIS. JofIMAB [Internet]. 2024 [cited 2025 Oct 3]; 30(4):5786–8. Available from: https://www.journal-imab-bg.org/issues-2024/issue4/vol30issue4p5786-5788.html.
  8. Fattorini F, Conticini E, Dourado E, Bottazzi F, Bruno L, Diomedi M, et al. Idiopathic inflammatory myopathies: one year in review 2025. Clinical and Experimental Rheumatology [Internet]. 2025 [cited 2025 Oct 3]. Available from: https://www.clinexprheumatol.org/abstract.asp?a=22220.
  9. Subramanian B, Kumarasami N, Shastry P, Sivasailam K, D A, R K, et al. A Multi-Site Study on AI-Driven Pathology Detection and Osteoarthritis Grading from Knee X-Ray [Internet]. arXiv; 2025 [cited 2025 Oct 3]. Available from: http://arxiv.org/abs/2503.22176.
  10. Dunn CM, Sturdy C, Velasco C, Schlupp L, Prinz E, Izda V, et al. Peripheral Blood DNA Methylation–Based Machine Learning Models for Prediction of Knee Osteoarthritis Progression: Biologic Specimens and Data From the Osteoarthritis Initiative and Johnston County Osteoarthritis Project. Arthritis & Rheumatology [Internet]. 2023 [cited 2025 Oct 3]; 75(1):28–40. Available from: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.42316.
  11. Abdusalomov A, Mirzakhalilov S, Umirzakova S, Ismailov O, Sultanov D, Nasimov R, et al. Lightweight early detection of knee osteoarthritis in athletes. Sci Rep [Internet]. 2025 [cited 2025 Oct 3]; 15(1):31413. Available from: https://www.nature.com/articles/s41598-025-04095-0.
  12. Crema MD, Roemer FW, Marra MD, Burstein D, Gold GE, Eckstein F, et al. Articular Cartilage in the Knee: Current MR Imaging Techniques and Applications in Clinical Practice and Research <sup/>. RadioGraphics [Internet]. 2011 [cited 2025 Oct 3]; 31(1):37–61. Available from: http://pubs.rsna.org/doi/10.1148/rg.311105084.
  13. Adedinsewo DA, Onietan D, Morales-Lara AC, Moideen Sheriff S, Afolabi BB, Kushimo OA, et al. Contextual challenges in implementing artificial intelligence for healthcare in low-resource environments: insights from the SPEC-AI Nigeria trial. Front Cardiovasc Med [Internet]. 2025 [cited 2025 Oct 3]; 12:1516088. Available from: https://www.frontiersin.org/articles/10.3389/fcvm.2025.1516088/full.
  14. Faiyazuddin Md, Rahman SJQ, Anand G, Siddiqui RK, Mehta R, Khatib MN, et al. The Impact of Artificial Intelligence on Healthcare: A Comprehensive Review of Advancements in Diagnostics, Treatment, and Operational Efficiency. Health Science Reports [Internet]. 2025 [cited 2025 Oct 3]; 8(1):e70312. Available from: https://onlinelibrary.wiley.com/doi/10.1002/hsr2.70312.
  15. Moingeon P. Intelligent Drugs: How AI is Transforming Healthcare [Internet]. Cham: Springer Nature Switzerland; 2025 [cited 2025 Oct 3]. Available from: https://link.springer.com/10.1007/978-3-031-91668-7.
  16. 16.   Akingbola A, Adeleke O, Idris A, Adewole O, Adegbesan A. Artificial Intelligence and the Dehumanization of Patient Care. Journal of Medicine, Surgery, and Public Health [Internet]. 2024 [cited 2025 Oct 3]; 3:100138. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2949916X24000914.
  17. Chustecki M. Benefits and Risks of AI in Health Care: Narrative Review. Interact J Med Res [Internet]. 2024 [cited 2025 Oct 3]; 13:e53616. Available from: https://www.i-jmr.org/2024/1/e53616.
  18.  Ethical Integration of Artificial Intelligence in Criminology: Addressing Challenges for a Safer Society. IRJMETS [Internet]. 2023 [cited 2025 Oct 3]. Available from: https://www.irjmets.com/uploadedfiles/paper//issue_6_june_2023/41779/final/fin_irjmets1686466596.pdf.
  19. Pruski M. Ethical Challenges to the Adoption of AI in Healthcare: A Review. The New Bioethics [Internet]. 2024 [cited 2025 Oct 3]; 30(4):251–67. Available from: https://www.tandfonline.com/doi/full/10.1080/20502877.2025.2541438.
  20. Nasir M, Siddiqui K, Ahmed S. Ethical-legal implications of AI-powered healthcare in critical perspective. Front Artif Intell [Internet]. 2025 [cited 2025 Oct 3]; 8. Available from: https://www.frontiersin.org/journals/artificial-intelligence/articles/10.3389/frai.2025.1619463/full.
  21. Stogiannos N, Georgiadou E, Rarri N, Malamateniou C. Ethical AI: A qualitative study exploring ethical challenges and solutions on the use of AI in medical imaging. European Journal of Radiology Artificial Intelligence [Internet]. 2025 [cited 2025 Oct 3]; 1:100006. Available from: https://linkinghub.elsevier.com/retrieve/pii/S3050577125000040.
  22. Shakilla U, Purwo Saputro E. Revolutionizing Management: The Role of AI and Technology in Modern Leadership Practices. SICOPUS [Internet]. 2024 [cited 2025 Oct 3]; 3(01):53–68. Available from: https://journal.walideminstitute.com/index.php/sicopus/article/view/235.
  23. Chen Y, Wu K. Integrating artificial intelligence into regional technological domains: the role of intra- and extra-regional AI relatedness. Cambridge Journal of Regions, Economy and Society [Internet]. 2025 [cited 2025 Oct 3]; 18(1):111–30. Available from: https://academic.oup.com/cjres/article/18/1/111/7950699.
  24. Doolub G, Khurshid S, Theriault-Lauzier P, Nolin Lapalme A, Tastet O, So D, et al. Revolutionising Acute Cardiac Care With Artificial Intelligence: Opportunities and Challenges. Canadian Journal of Cardiology [Internet]. 2024 [cited 2025 Oct 3]; 40(10):1813–27. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0828282X24004434.
  25. Da Silva A, Agarwal S. Doctor, What Should I Do About My Iliac Aneurysm, Could Artificial Intelligence Help? EJVES Vascular Forum [Internet]. 2024 [cited 2025 Oct 3]; 61:S25–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2666688X24000376.
  26. lauren.hoskin@nihr.ac.uk. AI in healthcare - 10 promising interventions. NIHR Evidence [Internet]. 2023 [cited 2025 Oct 3]. Available from: https://evidence.nihr.ac.uk/collection/artificial-intelligence-10-promising-interventions-for-healthcare/.
Share

Fatemeh Hashemzadeh

MRes in Tissue Engineering and Innovation Technology – King’s College London; MSc in Biophysics

Fatemeh is an interdisciplinary biomedical researcher with several years of experience in tissue engineering, molecular biophysics, genetic disorders, and wound-healing biomaterials. She has co-authored publications on nanotechnology-based drug delivery, biomolecular interactions, and biosensor design, and she also writes evidence-based medical articles for public audiences. Her long-term interests lie in MedTech and healthcare innovation, particularly in the development of next-generation, AI-enabled biomedical technologies.

arrow-right